| 產(chǎn)品編號 | 567741 |
| 品牌 | Sigma |
| 警告 | Toxicity: Standard Handling (A) |
| 測定 | ≥95% (HPLC) |
| 運輸 | ambient |
| 顏色 | off-white |
| 形式 | solid |
| 溶解性 | DMSO: 50?mg/mL |
| 分子量 | 465.60 |
| 其他說明 | Schnute, M.E., et al. 2012. Biochem. J.444, 79. |
| 儲存溫度 | 2-8°C |
| 質量水平 | 100 |
| 儲存條件 | OK to freeze
protect from light |
| MDL編號 | MFCD23098794 |
| 酶學委員會(EC)編號 | 465.6 |
別名
Sphingosine Kinase 1 Inhibitor II, PF-543 - CAS 1415562-82-1 - Calbiochem,SK Inhibitor II, ( R)-(1-(4-((3-Methyl-5-(phenylsulfonylmethyl)phenoxy)methyl)benzyl)-pyrrolidin-2-yl)methanol, Sphingosine Kinase Inhibitor II,SK Inhibitor II, (R)-(1-(4-((3-Methyl-5-(phenylsulfonylmethyl)phenoxy)methyl)benzyl)-pyrrolidin-2-yl)methanol, Sphingosine Kinase Inhibitor II
一般描述
A cell-permeable hydroxymethylpyrrolidine compound that acts as a high affinity (Kd = 5 nM, kofft1/2 = 8.5 min), but poor, sphingosine kinase-1/SphK1 substrate (1/1,500 of sphingosine processivity) and potently inhibits against SphK1-catalyzed sphingosine-to-S1P conversion (IC50 = 2.0 nM; [sphingosine] = 3 μM) in a reversible, sphingosine-, but not ATP-, competitive manner (Ki = 3.6 nM), exhibiting 132-fold selectivity over SphK2, no affinity toward S1P receptors (S1P1, S1P2, S1P3, S1P5), and much reduced or no inhibitory activity against a panel of 46 other lipid and protein kinases (IC50 >10 μM), including the structurally related diacylglyerol kinase α/DAGKα (3.7% inhibition at 10 μM). PF-543 exposure in 1483 squamous cultures is reported to result in intracellular S1P depletion (by 90% upon 1 h 200 nM or 7 d 1 μM drug exposure) with concomitant elevation of sphingosine level and no detectable cytotoxicity (1 μM for 7 to 9 d in 1483, A549, Jurkat, LN229, MCF7, or U937 cultures). Also active in human whole blood assays in the presence human & bovine serum proteins (IC50 = 26.7 nM against cellular C17-S1P formation from exogenously added 20 μM C17-sphingosine in 10 min with 30 min drug preincubation).
A cell-permeable hydroxymethylpyrrolidine compound that inhibits sphingosine kinase-1/SphK1-catalyzed Sphingosine phosphorylation (IC50 = 2.0 nM; [sphingosine] = 3 μM) in a reversible and sphingosine-competitive manner (Ki = 3.6 nM), exhibiting no affinity toward S1P receptors and much reduced inhibitory activity against Sphk2 (6.8% inhibition at 10 μM) or 46 other lipid and portein kinases (IC50 >10 μM). Effectively depletes cellular S1P (by 90% with 1 h 200 nM or 7 d 1 μM drug exposure in 1483 cultures) with concomitant elevation of sphingosine level and no detectable cytotoxicity.
重懸
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
關鍵字： Sphingosine Kinase 1 Inhibitor II, PF-543 - CAS 1415562-82-1 - Calbiochem;Sphingosine Kinase 1 Inhibitor II, PF-543 - CAS 1415562-82-1 - Calbiochem價格;Sphingosine Kinase 1 Inhibitor II, PF-543 - CAS 1415562-82-1 - Calbiochem廠家;1415562-82-1;Sigma
關于默克生命科學
我們擁有廣泛的高質量產(chǎn)品組合和解決方案，致力于推動科學研究，提高藥物研發(fā)和生物制藥生產(chǎn)的質量和效率，并為獲取準確可靠的診斷和檢測結果提供安全的保障。我們的愿景是使全球各地的人們能夠更快地獲得提升人類健康水平的解決方案。我們的共同目標是通過與全球科學界合作，解決生命科學中棘手的問題。
30萬個廣泛產(chǎn)品組合，其中包括業(yè)內(nèi)許多知名的品牌，Sigma-Alrdich?、Milli-Q?、 Supelco?、Millipore?、SAFC?和BioReliance?。
關于默克
是一家全球領先的科技公司，專注于醫(yī)藥健康、生命科學和電子科技三大領域。全球約有57,000名員工服務于默克，通過創(chuàng)造更加愉悅和可持續(xù)性的生活方式，為數(shù)百萬人的生活帶來積極的影響。從先進的基因編輯技術和發(fā)現(xiàn)治療最具挑戰(zhàn)性疾病的獨特方法，到實現(xiàn)設備的智能化——默克無處不在。
科學探索和負責任的企業(yè)精神一直是默克科技進步的關鍵，也是默克自1668年以來永葆活力的秘訣。默克家族作為公司的創(chuàng)始者至今仍持有默克大部分的股份，我們在全球都叫“默克”，僅美國和加拿大例外。默克的三大領域：醫(yī)藥健康、生命科學及電子科技在這兩個國家分別稱之為“EMD Serono”、“MilliporeSigma”和“EMD Electronics”。
默克在中國已經(jīng)有87年發(fā)展歷史，目前有超過4100名員工，在